BioWorld

Nov. 17, 2008

View Archived Issues

Market Woes Reshaping Exec Pay from Both Sides

Executive compensation did not escape the harsh glare of the public spotlight during the recent implosion of the financial service industry. (BioWorld Today) Read More

Pfizer Focus on Stem Cells Could Help Some Biotechs

Read More

New Stem Cell Type Shows Value of Sticking Together

Read More

HHS: VCs to Play Critical Role in Personalized Medicine

Read More

Other News To Note

Read More

Clinic Roundup

Read More

Earnings Roundup

Read More

Financings Roundup

Read More

U.S. Patent Disclosures

Read More